Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.3 (
ascorbate oxidase
)
778
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We evaluated the efficacies of five treatment procedures for eliminating ascorbate interference in the enzymatic determination of urinary
oxalate
. Aliquots of urine samples, containing different amounts of added ascorbate and
oxalate
, were individually subjected to ferric chloride, sodium nitrite, sodium periodate, charcoal, or
ascorbate oxidase
treatment to eliminate ascorbate interference. Oxalate contents of the urine samples were then determined by a banana oxalate oxidase-horseradish peroxidase-linked assay with 3-methyl-2-benzothiazolinone hydrazone and 3-(dimethylamino)benzoic acid as chromogens. Only those urine samples treated with
ascorbate oxidase
or charcoal consistently gave recovery of
oxalate
close to 100%. Treatment with other reagents, though improving the recovery of
oxalate
, gave inconsistent results. On the basis of these data, we describe procedures for simply and reliably assaying
oxalate
by using banana oxalate oxidase.
...
PMID:Five treatment procedures evaluated for the elimination of ascorbate interference in the enzymatic determination of urinary oxalate. 204 51
In an attempt to decrease ascorbate interference on the ion-chromatographic determination of urinary
oxalate
, we compared the effectiveness of four different methods for ascorbate elimination by analyzing a representative urine pool supplemented with successive ascorbate additions. Two of the methods--treatment with ferric ions or boric acid--have been described elsewhere; treatments with nitrites or
ascorbate oxidase
(
EC 1.10.3.3
) are investigated here as possible alternatives. Consideration of the main features, advantages, and drawbacks of the four procedures leads us to conclude that boric acid dilution is a good routine method and that pre-incubation with
ascorbate oxidase
reliably prevents ascorbate interference in assays of urinary
oxalate
.
...
PMID:Preventing ascorbate interference in ion-chromatographic determinations of urinary oxalate: four methods compared. 220 5
A continuous flow method is described for estimation of urinary
oxalate
, using oxalate oxidase (EC 1.2.3.4) and
ascorbate oxidase
(
EC 1.10.3.3
) immobilised on the inner surface of O-alkylated nylon tubes. Linearity, precision,
oxalate
recovery, freedom from interference by other urinary substances, accuracy, specificity, absence of interaction between samples and correlation with an established enzymic method were all excellent. The method has advantages over other methods in terms of speed, ease of use and cost. As the immobilised enzyme system has been stable for 15 months the method is suitable for both research and routine use.
...
PMID:Direct determination of urinary oxalate by a continuous flow method. 238 Dec 71
An enzymatic assay for the determination of
oxalate
in plasma was developed which is specific, simple, rapid and requires no specialised equipment; interference from vitamin C was removed by incubation of acidified plasma ultrafiltrate with
ascorbate oxidase
prior to
oxalate
estimation. Recoveries were 93 +/- 11% and the inter-batch coefficient of variation for 31 determinations at an
oxalate
level of 24 mumol/l was 10%. The assay is linear up to 300 mumol/l with a detection limit of 2 mumol/l. The reference range, based on results from 25 healthy volunteers, was defined as less than 2-5 mumol/l which is similar to levels established for the in vivo isotope dilution technique. The assay has an added advantage over the latter method, which requires a urine collection, in that it can be applied to plasma from anuric patients. A linear correlation (r = 0.68, p less than 0.001) was found between plasma
oxalate
and serum creatinine in individuals with varying degrees of renal failure.
...
PMID:A simple, rapid assay for plasma oxalate in uraemic patients using oxalate oxidase, which is free from vitamin C interference. 276 49
Ascorbic acid (vitamin C) is an abundant component of plants. It reaches a concentration of over 20 mM in chloroplasts and occurs in all cell compartments, including the cell wall. It has proposed functions in photosynthesis as an enzyme cofactor (including synthesis of ethylene, gibberellins and anthocyanins) and in control of cell growth. A biosynthetic pathway via GDP-mannose, GDP-L-galactose, L-galactose, and L-galactono-1,4-lactone has been proposed only recently and is supported by molecular genetic evidence from the ascorbate-deficient vtc 1 mutant of Arabidopsis thaliana. Other pathways via uronic acids could provide minor sources of ascorbate. Ascorbate, at least in some species, is a precursor of tartrate and
oxalate
. It has a major role in photosynthesis, acting in the Mehler peroxidase reaction with ascorbate peroxidase to regulate the redox state of photosynthetic electron carriers and as a cofactor for violaxanthin de-epoxidase, an enzyme involved in xanthophyll cycle-mediated photoprotection. The hypersensitivity of some of the vtc mutants to ozone and UV-B radiation, the rapid response of ascorbate peroxidase expression to (photo)-oxidative stress, and the properties of transgenic plants with altered ascorbate peroxidase activity all support an important antioxidative role for ascorbate. In relation to cell growth, ascorbate is a cofactor for prolyl hydroxylase that posttranslationally hydroxylates proline residues in cell wall hydroxyproline-rich glycoproteins required for cell division and expansion. Additionally, high
ascorbate oxidase
activity in the cell wall is correlated with areas of rapid cell expansion. It remains to be determined if this is a causal relationship and, if so, what is the mechanism. Identification of the biosynthetic pathway now opens the way to manipulating ascorbate biosynthesis in plants, and, along with the vtc mutants, this should contribute to a deeper understanding of the proposed functions of this multifaceted molecule.
...
PMID:Ascorbic acid in plants: biosynthesis and function. 1100 3
Increasing the L-ascorbate (vitamin C) content of crops could in principle involve promoting its biosynthesis or inhibiting its degradation. Recent progress has revealed biosynthetic pathways for ascorbate, but the degradative pathways remain unclear. The elucidation of such pathways could promote an understanding of the roles of ascorbate in plants, and especially of the intriguing positive correlation between growth rate and
ascorbate oxidase
(or its products). In some plants (Vitaceae), ascorbate is degraded via L-idonate to L-threarate (L-tartrate), with the latter arising from carbons 1-4 of ascorbate. In most plants, however (including Vitaceae), ascorbate degradation can occur via dehydroascorbate, yielding
oxalate
plus L-threonate, with the latter from carbons 3-6 of ascorbate. The metabolic steps between ascorbate and
oxalate
/L-threonate, and their subcellular location, were unknown. Here we show that this pathway operates extracellularly in cultured Rosa cells, proceeds via several novel intermediates including 4-O-oxalyl-L-threonate, and involves at least one new enzyme activity. The pathway can also operate non-enzymatically, potentially accounting for vitamin losses during cooking. Several steps in the pathway may generate peroxide; this may contribute to the role of ascorbate as a pro-oxidant that is potentially capable of loosening the plant cell wall and/or triggering an oxidative burst.
...
PMID:Vitamin C degradation in plant cells via enzymatic hydrolysis of 4-O-oxalyl-L-threonate. 1560 27